Nimotuzumab in Combination With Cisplatin and Docetaxel for Patients With Advanced Non-small Cell Lung Cancer

NCT00985998 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped no paticipants enrolled

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Nimotuzumab and chemotherapy

Sponsor

Biotech Pharmaceutical Co., Ltd.